- Home
- OPOF vs VSTM Comparison
OPOF vs VSTM Comparison
Compare OPOF & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPOF
- VSTM
- Stock Information
- Founded
- OPOF 1922
- VSTM 2010
- Country
- OPOF United States
- VSTM United States
- Employees
- OPOF N/A
- VSTM N/A
- Industry
- OPOF Major Banks
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- OPOF Finance
- VSTM Health Care
- Exchange
- OPOF Nasdaq
- VSTM Nasdaq
- Market Cap
- OPOF 90.5M
- VSTM 84.1M
- IPO Year
- OPOF N/A
- VSTM 2012
- Fundamental
- Price
- OPOF $19.65
- VSTM $3.48
- Analyst Decision
- OPOF
- VSTM Strong Buy
- Analyst Count
- OPOF 0
- VSTM 8
- Target Price
- OPOF N/A
- VSTM $14.57
- AVG Volume (30 Days)
- OPOF 2.0K
- VSTM 985.3K
- Earning Date
- OPOF 11-01-2024
- VSTM 11-06-2024
- Dividend Yield
- OPOF 2.90%
- VSTM N/A
- EPS Growth
- OPOF N/A
- VSTM N/A
- EPS
- OPOF 1.41
- VSTM N/A
- Revenue
- OPOF $58,406,000.00
- VSTM $10,000,000.00
- Revenue This Year
- OPOF N/A
- VSTM N/A
- Revenue Next Year
- OPOF N/A
- VSTM $125.69
- P/E Ratio
- OPOF $13.73
- VSTM N/A
- Revenue Growth
- OPOF N/A
- VSTM N/A
- 52 Week Low
- OPOF $13.49
- VSTM $2.10
- 52 Week High
- OPOF $20.26
- VSTM $14.22
- Technical
- Relative Strength Index (RSI)
- OPOF 59.50
- VSTM 61.73
- Support Level
- OPOF $18.80
- VSTM $2.93
- Resistance Level
- OPOF $19.50
- VSTM $3.76
- Average True Range (ATR)
- OPOF 0.21
- VSTM 0.26
- MACD
- OPOF 0.00
- VSTM 0.05
- Stochastic Oscillator
- OPOF 69.12
- VSTM 76.64
About OPOF Old Point Financial Corporation
Old Point Financial Corp functions in the financial services domain in the United States. As the holding company of The Bank and Trust, it is a nationally chartered trust and wealth management service, provider. Its suite of services includes commercial banking solutions such as loan, deposit and cash management, which are rendered through a chain of branches throughout the country. It operates through segments such as Bank, Wealth and Company.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.